1,000
Views
37
CrossRef citations to date
0
Altmetric
Biochemistry & Molecular Biology

Anti-HIV-1 activity of phlorotannin derivative 8,4‴-dieckol from Korean brown alga Ecklonia cava

, , , &
Pages 1151-1158 | Received 19 Nov 2013, Accepted 27 Feb 2014, Published online: 12 Jun 2014

References

  • Lam KS. New aspects of natural products in drug discovery. Trends Microbiol. 2007;15:279–289.10.1016/j.tim.2007.04.001
  • Zhou X, Liu J, Yang B, Lin X, Yang XW, Liu Y. Marine natural products with anti-HIV activities in the last decade. Curr. Med. Chem. 2013;20:953–973.
  • UN Joint Programme on HIV/AIDS (UNAIDS). Global report UNAIDS report on the global AIDS epidemic 2013 [cited 2013 Nov 6]. Available from: http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS_Global_Report_2013_en.pdf.
  • De Clercq E. Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV. Int. J. Antimicrob. Agents. 2009;33:307–320.10.1016/j.ijantimicag.2008.10.010
  • Johnson VA, Calvez V, Gunthard HF, Paredes R, Pillay D, Shafer RW, Wensing AM, Richman DD. Update of the drug resistance mutations in HIV-1: March 2013. Top Antivir. Med. 2013;21:4–12.
  • Worm S, Sabin C, Weber R, Reiss P, El‐Sadr W, Dabis F, De Wit S, Law M, Monforte AD, Friis‐Møller N, Kirk O, Fontas E, Weller I, Phillips A, Lundgren J. Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study. J. Infect. Dis. 2010;201:318–330.10.1086/649521
  • Flexner C. HIV drug development: the next 25 years. Nat. Rev. Drug Discovery. 2007;6:959–966.10.1038/nrd2336
  • Villa F, Gerwick L. Marine natural product drug discovery: Leads for treatment of inflammation, cancer, infections, and neurological disorders. Immunopharmacol. Immunotoxicol. 2010;32:228–237.10.3109/08923970903296136
  • Penesyan A, Kjelleberg S, Egan S. Development of novel drugs from marine surface associated microorganisms. Mar. Drugs. 2010;8:438–459.10.3390/md8030438
  • Mayer AMS, Rodríguez AD, Taglialatela-Scafati O, Fusetani N. Marine pharmacology in 2009–2011: Marine compounds with antibacterial, antidiabetic, antifungal, anti-Inflammatory, antiprotozoal, antituberculosis, and antiviral Activities; affecting the immune and nervous systems, and other miscellaneous mechanisms of action. Mar. Drugs. 2013;11:2510–2573.10.3390/md11072510
  • Nwosu F, Morris J, Lund V, Stewart D, Ross H. Anti-proliferative and potential anti-diabetic effects of phenolic-rich extracts from edible marine algae. Food Chem. 2011;126:1006–1012.10.1016/j.foodchem.2010.11.111
  • Erwin P, López-Legentil S, Schuhmann P. The pharmaceutical value of marine biodiversity for anti-cancer drug discovery. Ecol. Econ. 2010;70:445–451.10.1016/j.ecolecon.2010.09.030
  • Kong CS, Kim JA, Bak SS, Byun HG, Kim SK. Anti-obesity effect of carboxymethyl chitin by AMPK and aquaporin-7 pathways in 3T3-L1 adipocytes. J. Nutr. Biochem. 2011;22:276–281.10.1016/j.jnutbio.2010.02.005
  • Jiang Y, Ng TB, Wang CR, Zhang D, Cheng ZH, Liu ZK, Qiao WT, Geng YQ, Li N, Liu F. Inhibitors from natural products to HIV-1 reverse transcriptase, protease and integrase. Mini-Rev. Med. Chem. 2010;10:1331–1344.
  • Wijesekara I, Pangestuti R, Kim SK. Biological activities and potential health benefits of sulfated polysaccharides derived from marine algae. Carbohydr. Polym. 2011;84:14–21.10.1016/j.carbpol.2010.10.062
  • Lee SA, Hong SK, Suh CI, Oh MH, Park JH, Choi BW, Park SW, Paik SY. Anti-HIV-1 efficacy of extracts from medicinal plants. J. Microbiol. 2010;48:249–252.10.1007/s12275-009-0176-9
  • Li Y, Qian Z, Ryu BM, Lee SH, Kim MM, Kim SK. Chemical components and its antioxidant properties in vitro: an edible marine brown alga, Ecklonia cava. Bioorg. Med. Chem. 2009;17:1963–1973.10.1016/j.bmc.2009.01.031
  • Zheng YT, Zhang WF, Ben KL, Wang JH. In vitro immunotoxicity and cytotoxicity of trichosanthin against human normal immunocytes and leukemia-lymphoma cells. Immunopharmacol. Immunotoxicol. 1995;17:69–79.10.3109/08923979509052721
  • Zheng YT, Ben KL, Jin SW. Anti-HIV-1 activity of trichobitacin, a novel ribosome-inactivating protein. Acta Pharmacol. Sin. 2000;21:179–182.
  • Pauwels R, Balzarini J, Baba M, Snoeck R, Schols D, Herdewijn P, Desmyter J, De Clercq E. Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J. Virol. Methods. 1988;20:309–321.10.1016/0166-0934(88)90134-6
  • Kiser R, Makovsky S, Terpening SJ, Laing N, Clanton DJ. Assessment of a cytoprotection assay for the discovery and evaluation of anti-human immunodeficiency virus compounds utilizing a genetically-impaired virus. J. Virol. Methods. 1996;58:99–109.10.1016/0166-0934(95)01998-7
  • Lee DS, Jung KE, Yoon CH, Lim H, Bae YS. Newly designed six-membered azasugar nucleotide-containing phosphorothioate oligonucleotides as potent human immunodeficiency virus type 1 inhibitors. Antimicrob. Agents and Chemother. 2005;49:4110–4120.10.1128/AAC.49.10.4110-4120.2005
  • Derdeyn CA, Decker JM, Sfakianos JN, Wu X, O’Brien WA, Ratner L, Kappes JC, Shaw GM, Hunter E. Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120. J. Virol. 2000;74:8358–8367.10.1128/JVI.74.18.8358-8367.2000
  • Queffélec C, Bailly F, Mbemba G, Mouscadet JF, Hayes S, Debyser Z, Witvrouw M, Cotelle P. Synthesis and antiviral properties of some polyphenols related to Salvia genus. Bioorg. Med. Chem. Lett. 2008;18:4736–4740.10.1016/j.bmcl.2008.06.063
  • Yu D, Morris-Natschke SL, Lee KH. New developments in natural products-based anti-AIDS research. Med. Res. Rev. 2007;27:108–132.10.1002/(ISSN)1098-1128
  • Nakane H, Arisawa M, Fujita A, Koshimura S, Ono K. Inhibition of HIV-reverse transcriptase activity by some phloroglucinol derivatives. FEBS Lett. 1991;286:83–85.10.1016/0014-5793(91)80946-Z
  • Pal Singh I, Bharate SB. Phloroglucinol compounds of natural origin. Nat. Prod. Rep. 2006;23:558–591.10.1039/b600518g
  • Dutot M, Fagon R, Hemon M, Rat P. Antioxidant, anti-inflammatory, and anti-senescence activities of a phlorotannin-rich natural extract from brown seaweed Ascophyllum nodosum. Appl. Biochem. Biotechnol. 2012;167:2234–2240.10.1007/s12010-012-9761-1
  • Nagayama K, Iwamura Y, Shibata T, Hirayama I, Nakamura T. Bactericidal activity phlorotannins from the brown alga Ecklonia kurome. J. Antimicrob. Chemother. 2002;50:889–893.10.1093/jac/dkf222
  • Kim MM, Ta QV, Mendis E, Rajapakse N, Jung WK, Byun HG, Jeon YJ, Kim SK. Phlorotannins in Ecklonia cava extract inhibit matrix metalloproteinase activity. Life Sci. 2006;79:1436–1443.10.1016/j.lfs.2006.04.022
  • Ahn MJ, Yoon KD, Min SY, Lee JS, Kim JH, Kim TG, Kim SH, Kim NG, Huh H, Kim J. Inhibition of HIV-1 reverse transcriptase and protease by phlorotannins from the brown alga Ecklonia cava. Biol. Pharm. Bull. 2004;27:544–547.10.1248/bpb.27.544
  • Artan M, Li Y, Karadeniz F, Lee SH, Kim MM, Kim SK. Anti-HIV-1 activity of phloroglucinol derivative, 6,6′-bieckol, from Ecklonia cava. Bioorg. Med. Chem. 2008;16:7921–7926.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.